Challenges of Teledermatology: Lessons Learned During COVID-19 Pandemic. 2020

Hannah S Berman, and Vivian Y Shi, and Jennifer L Hsiao

The COVID-19 pandemic required a transition to telemedicine to limit viral spread. Dermatology seems particularly well-suited for telemedicine, however, this pandemic transformed teledermatology into the predominant means of delivering care. Providers are limited in their ability to promptly and accurately manage disease without access to in-person tools. This monumental switch to teledermatology may disadvantage certain patient populations, including those with limited technological literacy (such as the elderly) or access to the internet. Dermatologists must acknowledge these limitations and recognize the consequences of severely limited in-person visits over a prolonged period of time.

UI MeSH Term Description Entries
D003197 Computer Literacy Familiarity and comfort in using computers efficiently. Computer Literacies,Literacies, Computer,Literacy, Computer
D003880 Dermatology A medical specialty concerned with the skin, its structure, functions, diseases, and treatment.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077230 Internet Access Ability to connect to access services available on the Internet. Web Access,Access, Internet,Access, Web
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease
D017216 Telemedicine Delivery of health services via remote telecommunications. This includes interactive consultative and diagnostic services. Tele-Care,Tele-ICU,Tele-Intensive Care,Tele-Referral,Telecare,Virtual Medicine,Mobile Health,Telehealth,eHealth,mHealth,Health, Mobile,Medicine, Virtual,Tele Care,Tele ICU,Tele Intensive Care,Tele Referral,Tele-Referrals

Related Publications

Hannah S Berman, and Vivian Y Shi, and Jennifer L Hsiao
June 2020, Journal of drugs in dermatology : JDD,
Hannah S Berman, and Vivian Y Shi, and Jennifer L Hsiao
January 2022, Cutis,
Hannah S Berman, and Vivian Y Shi, and Jennifer L Hsiao
January 2024, American journal of clinical dermatology,
Hannah S Berman, and Vivian Y Shi, and Jennifer L Hsiao
October 2020, Journal of the American Academy of Dermatology,
Hannah S Berman, and Vivian Y Shi, and Jennifer L Hsiao
March 2023, JAMA,
Hannah S Berman, and Vivian Y Shi, and Jennifer L Hsiao
June 2020, Journal of the American College of Surgeons,
Hannah S Berman, and Vivian Y Shi, and Jennifer L Hsiao
January 2022, Current allergy and asthma reports,
Hannah S Berman, and Vivian Y Shi, and Jennifer L Hsiao
October 2021, The American journal of tropical medicine and hygiene,
Hannah S Berman, and Vivian Y Shi, and Jennifer L Hsiao
January 2021, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
Hannah S Berman, and Vivian Y Shi, and Jennifer L Hsiao
July 2023, Health science reports,
Copied contents to your clipboard!